Clinical Trial Update: Clonal Architecture of ASXL1-mutated Myelofibrosis [NA]

View source ↗

Summary

This clinical trial update indicates a study on the clonal architecture of ASXL1-mutated myelofibrosis is currently recruiting at University Hospital, Angers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Snippet

Sponsor: University Hospital, Angers | Conditions: Myelofibrosis | NA | Status: RECRUITING